icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
Early versus delayed use of sofosbuvir plus peginterferon/ribavirin therapy in fibrosis patients with hepatitis C virus: a cost-effectiveness analysis
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
M. Buti1, R. Domínguez-Hernández2, I. Oyagüez2, M. Rueda3, MA. Casado2 1Hospital Vall' d'Hebron, Barcelona, Spain; 2Pharmacoeconomics & Outcomes Research Iberia, Madrid, Spain; 3Gilead Sciences, Madrid, Spain.

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif